Cancer Research Priority Area

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Oct 29, 2020, 8:29 AM

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Evers_Mark_Director%20Markey%20Cancer%20Ctr_1.jpg

Evers Elected to the National Academy of Medicine

Oct 20, 2020, 8:18 AM

Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

UK Study Highlights Need for Genetic Testing for Kentucky Patients with Lung Cancer

Sep 23, 2020, 9:58 AM

Recently published in PLOS One, the study used Kentucky Cancer Registry patient data from 2007-2011 to identify trends in epidermal growth factor receptor (EGFR) mutation testing and the usage of the EGFR inhibitor, erlotinib.

Markey Joins National Cancer Consortium to Address the Impact of COVID-19 on Cancer

Sep 22, 2020, 8:12 AM

Markey has joined a consortium of 17 cancer centers across the country to better understand how COVID-19 has impacted cancer prevention, detection and care.

Nathan%20Vanderford%20headshot%20on%20canvas.jpg

Vanderford Honored With Hartford-Nicholson Award From SRAI

Sep 3, 2020, 8:47 AM

In 2018, Vanderford was also named a recipient of the SRAI Mid-Career Level Excellence Award. Vanderford also serves as assistant director for research at the UK Markey Cancer Center, where he oversees a special oncology training program for Appalachian students, ACTION.

Cancer, COVID and the Kentucky Economy: How 'Sweet Annie' Could Make an Impact

Aug 11, 2020, 8:19 AM

Artemisia annua or "Sweet Annie" has been used as a medicinal herb for centuries. With potential to treat a variety of cancers & even COVID-19, this plant is more relevant than ever & UK is showing how we can take it from Kentucky fields to the lab to our patients.

Kuhs Named Co-Leader of Markey Cancer Prevention & Control Research Program

Aug 4, 2020, 8:21 AM

As a cancer prevention researcher trained in both basic laboratory science and epidemiology, Kuhs’ experience allows her to apply basic science findings to population-based studies, which will be essential to lowering cancer rates in the hardest-hit areas of the state.

Outreach Shows Progress, Promise in Fighting Oral Cancer Despite COVID-19

Jul 29, 2020, 8:26 AM

Kentucky has one of the nation's highest incidences of oral cancer, according to the National Institutes of Health, and the prevalence of oral cancer in the targeted counties is as much as 54% higher than the state average.

UK Study Provides New Insight on Colorectal Cancer Growth

Jul 14, 2020, 8:40 AM

A group led by the Markey Cancer Center researcher Qing-Bai She discovered that SMS is overexpressed in colorectal cancers and plays an important role in balancing cellular spermidine levels that are a necessary adaptation for colorectal cancer growth.

UK, ArtemiLife Partner to Test for Anti-Cancer Activity of Artemisia Annua Extracts

Jun 3, 2020, 8:28 AM

UK and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.

Subscribe to Cancer Research Priority Area